Weed (BUDZ) Selling, General & Administrative (2010 - 2026)
Weed (BUDZ) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 304.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 588.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 5.21 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 184.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 928.80 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 318.50 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 381.00 Mn |
| 10 | Weed | 3.10 Mn | 3.10 Mn | - | 67,833.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67,833.00 |
| Dec 31, 2025 | 622,258.00 |
| Sep 30, 2025 | 58,519.00 |
| Jun 30, 2025 | 64,052.00 |
| Mar 31, 2025 | 383,268.00 |
| Dec 31, 2024 | 64,422.00 |
| Sep 30, 2024 | 64,833.00 |
| Jun 30, 2024 | 85,296.00 |
| Mar 31, 2024 | 136,565.00 |
| Dec 31, 2023 | 126,750.00 |
| Sep 30, 2023 | 25,355.00 |
| Jun 30, 2023 | 108,730.00 |
| Mar 31, 2023 | 133,782.00 |
| Dec 31, 2022 | 143,648.00 |
| Sep 30, 2022 | 110,903.00 |
| Jun 30, 2022 | 175,818.00 |
| Mar 31, 2022 | 136,790.00 |
| Dec 31, 2021 | 206,495.00 |
| Sep 30, 2021 | 56,877.00 |
| Jun 30, 2021 | 76,765.00 |